Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724628 | SCV000230331 | uncertain significance | not provided | 2017-04-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000178279 | SCV000514678 | benign | not specified | 2015-03-31 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV002314641 | SCV000848838 | likely benign | Inborn genetic diseases | 2017-01-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001084789 | SCV001008518 | benign | GLUT1 deficiency syndrome 1, autosomal recessive | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000724628 | SCV002562919 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | SLC2A1: BP4, BP7 |